← Leaderboards
Paola A Betancur
University Of California, San Francisco
$597,294
Attributed
$597,294
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.1K · FY2019–21$200K$150K$100K$50K$0
'19
'20
'21
Funding mix
By agency
NIH$597,294 · 1
By mechanism
K22$597,294 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jeroen Roose$17,743,720
- Trever G Bivona$22,714,857
- Catherine Choy Smith$4,365,274
- Ralph S Marcucio$11,671,496
- Hilde Schjerven$2,179,645
Others in their field
Other Emerging Leaders on “Acute T-Cell Lymphoblastic Leukemia Cell”
- Weiqiang Chen · New York University$3,255,344
- Ksenia Matlawska-Wasowska · University Of New Mexico Health Scis Ctr$2,482,384
- Chintan Parekh · Children'S Hospital Of Los Angeles$2,056,760
- Paul Trippier · University Of Nebraska Medical Center$2,023,010
- Qingfei Jiang · University Of California, San Diego$1,842,610
- Evan William Weber · Children'S Hosp Of Philadelphia$1,825,998
Research focus
Acute T-Cell Lymphoblastic Leukemia CellEnhancersAutomobile DrivingAffectBindingAnti-Cd47Breast Cancer CellCancer CellBaseCancerousCancer TherapyCancer TypeCd47 GeneBinding SitesCell InjuryCell LineCellsCell Surface ProteinsCell TypeChip-SeqDevelopmental ProcessDistalEatingEpigenetic Process
Grant awards (3)
Identification of Novel Gene Regulatory Interactions Driving the Immune Evasion Program Through Transcriptional Activation of CD47 in Cancer$199,098
K22 · FY2021 · CA · contact PI
Identification of Novel Gene Regulatory Interactions Driving the Immune Evasion Program Through Transcriptional Activation of CD47 in Cancer$199,098
K22 · FY2020 · CA · contact PI
Identification of Novel Gene Regulatory Interactions Driving the Immune Evasion Program Through Transcriptional Activation of CD47 in Cancer$199,098
K22 · FY2019 · CA · contact PI